Literature DB >> 33609462

N6-methyladenosine modification of MALAT1 promotes metastasis via reshaping nuclear speckles.

Xinyu Wang1, Chong Liu2, Siwei Zhang2, Huiwen Yan3, Liwen Zhang3, Amin Jiang4, Yong Liu5, Yun Feng6, Di Li5, Yuting Guo5, Xinyao Hu5, Yajing Lin5, Pengcheng Bu3, Dong Li7.   

Abstract

N6-methyladenosine (m6A), one of the most prevalent RNA post-transcriptional modifications, is involved in numerous biological processes. In previous studies, the functions of m6A were typically identified by perturbing the activity of the methyltransferase complex. Here, we dissect the contribution of m6A to an individual-long noncoding RNA-metastasis-associated lung adenocarcinoma transcript 1 (MALAT1). The mutant MALAT1 lacking m6A-motifs significantly suppressed the metastatic potential of cancer cells both in vitro and in vivo in mouse. Super-resolution imaging showed that the concatenated m6A residues on MALAT1 acted as a scaffold for recruiting YTH-domain-containing protein 1 (YTHDC1) to nuclear speckles. We further reveal that the recognition of MALAT1-m6A by YTHDC1 played a critical role in maintaining the composition and genomic binding sites of nuclear speckles, which regulate the expression of several key oncogenes. Furthermore, artificially tethering YTHDC1 onto m6A-deficient MALAT1 largely rescues the metastatic potential of cancer cells.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MALAT1 long noncoding RNA; RNA m(6)A modification; YTHDC1; metastasis; nuclear speckles

Year:  2021        PMID: 33609462     DOI: 10.1016/j.devcel.2021.01.015

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  23 in total

1.  Structural effects of m6A modification of the Xist A-repeat AUCG tetraloop and its recognition by YTHDC1.

Authors:  Alisha N Jones; Ekaterina Tikhaia; André Mourão; Michael Sattler
Journal:  Nucleic Acids Res       Date:  2022-02-28       Impact factor: 16.971

Review 2.  Hidden codes in mRNA: Control of gene expression by m6A.

Authors:  Shino Murakami; Samie R Jaffrey
Journal:  Mol Cell       Date:  2022-06-16       Impact factor: 19.328

Review 3.  The Emerging Role of Long Non-Coding RNAs in Esophageal Cancer: Functions in Tumorigenesis and Clinical Implications.

Authors:  Yali Han; Guo Zhao; Xinhang Shi; Yushan Wang; Xin Wen; Lu Zhang; Xiangqian Guo
Journal:  Front Pharmacol       Date:  2022-05-13       Impact factor: 5.988

Review 4.  Biological roles of adenine methylation in RNA.

Authors:  Konstantinos Boulias; Eric Lieberman Greer
Journal:  Nat Rev Genet       Date:  2022-10-19       Impact factor: 59.581

Review 5.  Elucidating the Functions of Non-Coding RNAs from the Perspective of RNA Modifications.

Authors:  Venkata Naga Srikanth Garikipati; Shizuka Uchida
Journal:  Noncoding RNA       Date:  2021-05-11

Review 6.  Long Non-Coding RNA Epigenetics.

Authors:  Marek Kazimierczyk; Jan Wrzesinski
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

7.  The m6A landscape of polyadenylated nuclear (PAN) RNA and its related methylome in the context of KSHV replication.

Authors:  Sarah Elizabeth Martin; Huachen Gan; Gabriela Toomer; Nikitha Sridhar; Joanna Sztuba-Solinska
Journal:  RNA       Date:  2021-06-29       Impact factor: 5.636

8.  LncRNA-AK137033 inhibits the osteogenic potential of adipose-derived stem cells in diabetic osteoporosis by regulating Wnt signaling pathway via DNA methylation.

Authors:  Shuanglin Peng; Yujin Gao; Sirong Shi; Dan Zhao; Huayue Cao; Ting Fu; Xiaoxiao Cai; Jingang Xiao
Journal:  Cell Prolif       Date:  2021-12-24       Impact factor: 6.831

Review 9.  Modulation of Phase Separation by RNA: A Glimpse on N6-Methyladenosine Modification.

Authors:  Yingfeng Su; Yasen Maimaitiyiming; Lingfang Wang; Xiaodong Cheng; Chih-Hung Hsu
Journal:  Front Cell Dev Biol       Date:  2021-12-10

Review 10.  Long RNA-Mediated Chromatin Regulation in Fission Yeast and Mammals.

Authors:  Matthew W Faber; Tommy V Vo
Journal:  Int J Mol Sci       Date:  2022-01-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.